Profile
ABIO VRTX REGN SGEN ALNY ARGX
Company Name ARCA biopharma, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $34.82M $116.96B $54.11B $43.15B $38.15B $33.66B
Employees 0.00K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Mr. Thomas A. Keuer Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ABIO VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 1
Quant Rating Sell Sell Buy Neutral Strong Sell Strong Sell
Trading
ABIO VRTX REGN SGEN ALNY ARGX
Last Close $28.8 $445.82 $520.29 $228.74 $321.94 $560.53
High 52 $28.8 $516.74 $1201.76 $228.74 $325 $671.75
Low 52 $2.4 $396.64 $482.92 $228.74 $224.58 $430.04
Price vs. 52 Week High 0 % -13.72 % -56.71 % 0 % -0.94 % -16.56 %
Price vs. 52 Week Low 1100 % 12.4 % 7.74 % 0 % 43.35 % 30.34 %
Total Return
ABIO VRTX REGN SGEN ALNY ARGX
1 Month Return 0 % 2.25 % -11.57 % 0 % 11.03 % -4.61 %
3 Month Return 0 % -10.89 % -18.72 % 0 % 19.59 % -3.96 %
6 Month Return 0 % 8.56 % -27.4 % 0 % 32.76 % -11.31 %
9 Month Return 0 % -3.74 % -49.97 % 0 % 17.25 % 6.85 %
YTD Return 0 % 10.71 % -26.96 % 0 % 36.82 % -8.86 %
1 Year Return 729.73 % -5.95 % -51.34 % 0 % 31.31 % 25.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABIO VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) 72.73 % - 0.35 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -2006.69 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) 20.95 % - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
ABIO VRTX REGN SGEN ALNY ARGX
Asset Growth -12.12 % -0.87 % 12.32 %
Gross Profit Growth 2.63 % 10.25 % 26.81 %
Revenue Growth - 11.66 % 22.97 %
Revenue 3 Year - 45.6 % 147.1 %
Revenue 5 Year - 163.93 % 775.72 %
Revenue 10 Year - 1632.15 % 2487.4 %
EBIT Growth 100 % -93.69 % 24.59 %
Net Income Growth 42.32 % -114.8 % 36.82 %
Net Income 3 Yeari Growth Per Share 82.09 % -122.89 % 69.73 %
Net Income 5 Yeari Growth Per Share 96.41 % -145.38 % 73.13 %
Net Income 10 Yeari Growth Per Share 99.63 % 33.84 % 55.09 %
Operating Income Growth 31.14 % -106.08 % 37.31 %
Operating Cash Flow Growth (CFG) 54.05 % -113.93 % -107.98 %
Operating 3 Year CFG 78.79 % -118.65 % 98.8 %
Operating 5 Year CFG 96.75 % -131.3 % 97.44 %
Operating 10 Year CFG 99.55 % 12.43 % 97.08 %
EPS Growth 42.19 % -114.8 % 38.64 %
EPS Diluted Growth 42.19 % -114.97 % 38.64 %
Book Value Per Share -11.2 % -6.59 % 157.17 %
Share Holder 3 Year Equity Growth Per Share -74 % 62.6 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -67.24 % 168.85 % -96.01 %
Share Holder 10 Year Equity Growth Per Share -98.87 % 1265.7 % -95.83 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth - 116.42 % -51.69 %
Free Cash Flow Growth 54.06 % -124.1 % -201.54 %
Updated On 31 Dec 2023 31 Dec 2024 31 Dec 2024
Profitability
ABIO VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -6.81 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -13.26 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -16.36 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 42.98 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -2754.7 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM 0.01 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM - 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -0.63 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -0.63 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 837.57 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.05 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -2754.7 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -1.33 -92.97 17.92 -81.26 -506.05 -433.65
Price To Operating Cash Flows Ratio TTM -46.01 -119.36 13.76 -93.1 -841.05 -515.25
Price Cash Flow Ratio TTM -46.01 -119.36 13.76 -93.1 -841.05 -515.25
Income Statement (TTM)
ABIO VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $-0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.01B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -0.37 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
ABIO VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0.04B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.04B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
ABIO VRTX REGN SGEN ALNY ARGX
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 40.67
AARD Aardvark Therapeutics, Inc. Common Stock 13.95
ABCL AbCellera Biologics Inc. 3.7376
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.91
ABOS Acumen Pharmaceuticals, Inc. 1.225
ABPWW 0.0292
ABSI Absci Corporation 2.71
ABUS Arbutus Biopharma Corporation 3.195
ABVC ABVC BioPharma, Inc. 2.175
ABVX Abivax SA American Depositary Shares 7.15
ACAD ACADIA Pharmaceuticals Inc. 22.22
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6714
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.49
ACIU AC Immune SA 2.095
ACLX Arcellx, Inc. 64.835
ETFs With Exposure to ABIO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 302.04
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 133.77
VXF Vanguard Extended Market Index Fund 0 191.48
IWC iShares Micro-Cap ETF 0.00857 127.655
DFAT Dimensional U.S. Targeted Value ETF 0.00015047 53.885
VTSAX Vanguard Total Stock Market Index Fund 0 145.69
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 143.65
VITSX Vanguard Total Stock Market Index Fund 0 145.72
DFSU Dimensional US Sustainability Core 1 ETF 0.00000116 38.885
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000237478 102.76
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 143.66
SOLR SmartETFs Sustainable Energy II ETF 2.24 27.355
DCOR Dimensional ETF Trust 0.00000603 66.315
VEMPX Vanguard Extended Market Index InstlPlus 0 354.51
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 273.35
Unlock